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Abstract The membrane-type matrix metalloproteinases (MT-
MMPs) are a subclass of the matrix metalloproteinase (MMP)
family which uniquely possess a C-terminal transmembrane
domain and are initiators of an activation cascade for
progelatinase A (MMP-2). Recent studies have shown that they
can also efficiently directly degrade a number of matrix
macromolecules. We now show that cells expressing MT1-
MMP on their cell surfaces cause subjacent proteolysis of a
gelatin film and that this proteolysis is inhibited by TIMP-2 but
not by TIMP-1. These data indicate that expression of MT1-
MMP on the cell surface may lead to both progelatinase A
activation and extracellular matrix degradation.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The description of a subclass of the family of matrix metal-
loproteinases that are membrane associated, the membrane-
type matrix metalloproteinases (MT-MMPs), has focussed
largely on their ability to act as initiators of the activation
of progelatinase A. Most studies have concentrated on MT1-
MMP, which has been shown to be displayed on the surface
of activated cells [1]. Studies to de¢ne its mechanism of action
have shown that this is due to the formation of an MT-MMP-
TIMP-2 complex as a ‘receptor’ for progelatinase A which is
processed sequentially by active MT1-MMP and active gelat-
inase A [2,3]. The structural similarity of the catalytic domain
of MT1-MMP with that of other MMPs strongly suggests
that they also should be able to degrade ECM components,
and the ability of MT1-MMP to digest several ECM macro-
molecules has been con¢rmed biochemically [4^7]. Using con-
focal microscopy, we have studied degradation of £uores-
cently labelled gelatin ¢lms by cells expressing MT1-MMP,
comparing ¢broblast cells (HIFFs) that naturally express
MT1-MMP, with CHO cells transfected with MT1-MMP
cDNA. We now show that cells expressing MT1-MMP on
the cell surface can focally degrade £uorescently labelled gel-
atin ¢lms, and that this degradation may be inhibited by ad-
dition of recombinant TIMP-2 but not TIMP-1.
2. Materials and methods
2.1. Expression and puri¢cation of the GST-vMT1-MMP fusion
protein in order to raise a polyclonal antibody
A C-terminally truncated form of MT1-MMP, lacking the trans-
membrane domain (residues 511^582), vMT1-MMP, was expressed
intracellularly in Escherichia coli as a fusion protein with glutathione
S-transferase (GST) using the pGEX system [8]. To generate MT1-
MMP, PCR was carried out with MT1-MMP cDNA [1] using the
primers 5P-CGTAGATCTGCGCTCGCCTCCCTCGGC-3P (R6662)
and 5P-AAAAGATCTCATGGGCAGCCCATCCAGTC-3P (R6310).
Ampli¢ed DNA was cloned into pIJ2925 [9] at the BglII site and the
nucleotide sequence was determined from the 5P end to the down-
stream SmaI site and from the 3P end to the upstream BamHI site
using the Sequenase kit version 1.0 (United States Biochemical). The
ampli¢ed DNA was replaced by the original cDNA between the SmaI
and the BamHI sites. After digestion with BglII the DNA was sub-
cloned into the pGEX-2T plasmid at the BamHI site to encode a
GST-vMT1-MMP fusion protein. The DNA was expressed in E. coli
DH5K with isopropyl-L-D-galactoside (0.1 mM) induction. Cells were
collected by centrifugation and resuspended in PBS (1 ml/l of cell
broth). The cells were disrupted by sonication and the inclusion
bodies were washed to remove contaminating E. coli proteins. Triton
X-100 was added to a ¢nal concentration of 1%. Reducing sample
bu¡er was added to the inclusion body suspension which was then
electrophoresed using a 3.5 mm thick SDS-polyacrylamide gel. After
migration, GST-vMT1-MMP was detected as a 70 kDa band by
staining with Coomassie blue and was electro-eluted with 0.025%
SDS, 25 mM Tris, 192 mM glycine at 100 V overnight at 4‡C. The
preparation was dialysed overnight at 4‡C against 2.5% Triton X-100,
50 mM Tris-HC1 pH 7.4, 5 mM CaCl2. Protein concentration was
estimated and protein purity was checked by SDS PAGE, followed by
silver staining and Western blotting using a goat anti-GST polyclonal
antibody (Pharmacia).
2.2. Preparation of E217A mutant MT1-MMP and eukaryotic
expression
A cDNA encoding a catalytically inactive form of MT1-MMP was
made by site-directed mutagenesis using PCR overlap extension muta-
genesis [10] to replace the glutamic acid residue within the zinc bind-
ing helix with an alanine residue. Such mutations have been shown to
dramatically reduce the catalytic capability of MMPs. The eukaryotic
expression construct was produced in essentially three steps. Firstly,
the site-directed mutation was made in the existing pGEX plasmid
described above. Secondly, the truncated MT1-MMP cDNA was in-
serted into the eukaryotic expression vector to generate an ‘in frame’
fusion with the tPA secretion signal. Thirdly, the 3P end of the original
MT1-MMP cDNA was replaced to produce the full length E217A
mutant cDNA.
Oligonucleotide R6662 was used with the mutagenic oligonucleotide
5P-CCCCAGGGCATGGCCCAGCGCGTGCACAGCCACCAGG-
AG-3P to generate a 680 nt ampli¢cation product. Similarly, the oli-
gonucleotides R6310 and 5P-CTTCCTGGTGGCTGTGCACGC-
GCTGGGCCATGCCCTGGGG-3P produced a 840 nt product. The
ampli¢cation products were puri¢ed, mixed and used as a template for
a PCR reaction using oligonucleotides 5P-GAAAGCTTCCATGGC-
GACAGGACGG-3P and 5P-TCACTGGAATTCTCGAGCCCCAG-
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GGCA-3P. The 208 nt product was digested with NcoI and XhoI and
the resulting 187 nt fragment was puri¢ed and ligated using the same
restriction enzyme sites into the pIJ2925 plasmid carrying the MT1-
MMP vTM cDNA described above. The ligation mixture was used to
transform competent cells of E. coli DH5K and colonies were screened
by nucleotide sequence analysis for the desired ECA mutation.
The BglII DNA fragment encoding the E217A mutant vTM form
was puri¢ed and subcloned into the eukaryotic expression vector
pEE14.tPA [11,12]. This inserted the cDNA in the appropriate trans-
lational reading frame with the tPA secretion signal sequence. Thus,
the tPA signal peptide, which has been used to successfully produce
many secreted proteins at relatively high levels, replaced the natural
signal peptide of MT1-MMP. Full length cDNA was reformed by
replacement of the 2.55 kbp XhoI-EcoRI fragment puri¢ed from the
parental MT1-MMP cDNA.
2.3. Cell culture
Human infant foreskin ¢broblasts (HIFFs) were prepared and sub-
cultured as described [13]. Cells from passages 4^7 were used for the
monolayer experiments, plated onto glass coverslips and cultured for
3 days in DMEM supplemented with 10% FBS at 37‡C with 5% CO2.
Media were changed to either DMEM alone, DMEM with 2% parti-
ally puri¢ed cytokines (largely interleukin 1L [14]), DMEM with 2%
partially puri¢ed cytokines with oncostatin M (Sigma, 50 ng/ml) or
DMEM with phorbol myristate acetate (PMA; Sigma, 10 ng/ml), and
the cells cultured for 24 h. Monensin (Sigma, 5 WM) was added for the
last 19 h of the culture period. Cells were then ¢xed for immunolo-
calisation.
To prepare cell lysates, HIFFs were cultured in 75 cm2 £asks in
DMEM supplemented with 10% FBS. At con£uence the cell layers
were washed with serum free DMEM and then cultured in this me-
dium for a further 24 h with or without PMA at 10 ng/ml. At harvest,
cells were washed twice with ice-cold PBS and lysed using a bu¡er of
50 mM Tris-HCl, pH 8.0, containing 1% Triton X-100 0.15 M NaCl,
0.02% sodium azide, 10 mM EDTA, 1 Wg/ml pepstatin A, 100 WM
phenylmethylsulphonyl £uoride and 1 Wg/ml E-64 (L-trans-epoxysuc-
cinyl-leucylamido (4-guanidino) butane). A volume of 400 Wl of ice-
cold lysis bu¡er was used for each 75 cm2 £ask. Cells were scraped
into lysis bu¡er, centrifuged in a microfuge for 10 min at 4‡C and the
supernatant was stored at 370‡C.
CHO-L761H cells [15] were maintained in DMEM supplemented
with 10% FBS and passaged with trypsin-EDTA. Cell lysates were
prepared from cells that were grown in 55 cm2 petri dishes and then
transfected with either control vector or MT1-MMP cDNAs as de-
scribed below. CHO-L761H cells are known to synthesise very low
levels of progelatinases A and B that are not detectable by immuno-
localisation.
2.4. Preparation of sheep antiserum to MT1-MMP
150 Wg puri¢ed GST-vMT1-MMP (1 ml) was emulsi¢ed in 1 ml
complete Freund’s adjuvant and injected into multiple intramuscular
sites in a Clun sheep. Booster injections of 100 Wg (0.5 ml prepared
similarly) were given on days 42 and 307. Blood was removed on days
7, 10 and 14 following each boost injection. Immunoglobulins (IgG)
were prepared by triple ammonium sulphate precipitation from the
bleed with the highest titre (bleed 6). The fraction of IgGs correspond-
ing to antibodies directed to GST was separated from total IgGs by
a⁄nity chromatography using a GST-Sepharose-glutathione column.
To prepare this column, soluble GST was obtained by intracellular
expression in E. coli transformed with pGEX-2T plasmid followed by
sonication of cells, and then coupled to CNBr-activated Sepharose B.
After washing the GST-Sepharose column with PBS, IgGs were
passed through the column, unbound material was collected and the
A280 was determined. A⁄nity puri¢ed antibody to MT1-MMP was
prepared by adsorption of the IgG to the catalytic domain of MT1-
MMP [16] immobilised on nitrocellulose. Speci¢c antibodies were
eluted from the nitrocellulose using a pH 2.8 glycine bu¡er, followed
by neutralisation using 2 M Tris-HCl pH 8.0.
2.5. Western blotting
Recombinant MMPs and TIMPs [22,23] (0.2^0.5 Wg) or 10 Wl cell
lysate were separated on an SDS-10% polyacrylamide gel under re-
ducing conditions and transferred by electroblotting to nitrocellulose
membranes (Hybond ECL, Amersham). The membranes were probed
with a⁄nity puri¢ed sheep anti-human vMT1-MMP (5 Wg/ml). Bound
antibody was revealed using a peroxidase conjugated second anti-
body, followed by incubation with a chemiluminescent substrate
(SuperSignal Substrate, Pierce, Rockford, IL). Luminescence was de-
tected by exposure to autoradiographic ¢lm (Hyper¢lm-ECL, Amer-
sham).
2.6. Preparation of gelatin-TR ¢lms
10 mg gelatin (Sigma) was dissolved in 1 ml 0.1 M sodium bicar-
bonate pH 9.0. Texas red sulphonyl chloride (Molecular Probes, Eu-
gene, OR; 1 mg) was dissolved in 100 Wl dry dimethyl formamide,
added dropwise to the gelatin solution and stirred (30 min, 4‡C).
Conjugated gelatin-Texas red (gelatin-TR) was separated from uncon-
jugated dye by passing through a Sephadex G25 column equilibrated
with PBS, and stored at 4‡C until use.
Eight well Labtek slides (ICN Biomedicals) were coated with poly-
L-lysine (Sigma; 10 Wg in 200 Wl H20 per well, 1 h, rt) followed by
gelatin-TR (10 Wl in 200 Wl H2O per well, 2 h, rt). This was removed
and the coating ¢xed with 4% formaldehyde (5 min, rt), washed three
times with PBS and unreacted aldehyde groups blocked with ammo-
nium chloride (50 WM in PBS, 10 min, rt). After repeated washing in
sterile PBS, 400 Wl DMEM with 10% FBS was added to each well and
incubated overnight (37‡C, 5% CO2/air) prior to plating cells.
CHO-L761H cells were plated onto Labtek slides at 3.2U104 cells
per well and cultured in DMEM supplemented with 10% FBS at
37‡C, with 5% CO2 for 24 h. Transfection was performed essentially
according to Chen and Okayama [17]. Either pEE14 MT1-MMP,
pEE14 E217A MT1-MMP, or pEE14 vector only (2.5 Wg DNA/
cm2/well) were co-precipitated with calcium phosphate and incubated
with the cells for 4 h at 37‡C. Media were removed and the cells
exposed to 15% glycerol in DMEM for 1 min. After washing in
DMEM, the cells were cultured in DMEM with 10% FBS, 37‡C,
5% CO2 for 3 h. Media were then replaced with DMEM only for a
further 16 h prior to immunolocalisation. Either recombinant human




MT1-MMP mediated ¢lm degradation occurs in the presence of TIMP-1 but not TIMP-2 and is increased by addition of progelatinase A




Vector ^ 3 0
MT1 ^ + 1651 þ 254
E217A-MT1 ^ + 0
MT1 rTIMP-1 + 1066 þ 131
MT1 rTIMP-2 + 0
MT1 CT1399 + 0
MT1 Aprotinin + 1681 þ 790
MT1 pGLA 0.001 Wg + 3803 þ 527
MT1 pGLA 0.01 Wg + 5004 þ 520
MT1 pGLA 0.1 Wg + 8409 þ 1048
CHO cells were plated onto gelatin-TR ¢lms and transfected with either vector (V), MT1-MMP (MT1) or E217A MT1-MMP (E217A-MT1) cDNA
as described in Section 2. Either rTIMP-1 (10 Wg/well), rTIMP-2 (10 Wg/well), CT1399 (10 WM), aprotinin (10 Wg/ml) or progelatinase A (pGLA,
0.001^1.0 Wg/well) were added to some wells. Cells were stained with anti-MT1-MMP IgG, observed by confocal microscopy and scored for cell
surface immuno£uorescence and focal degradation of the ¢lms.
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yl)-2-cyclohexyl-ethyl)-2-(R)-(4 chlorophenyl-propyl) succinamide;
Celltech, Slough; 10 WM), aprotinin (Bayer AG; 10 Wg/ml) or re-
combinant progelatinase A (0.001^1.0 Wg/well) were added to some
wells after the glycerol shock and also included in the serum-free
incubations.
2.7. Immunolocalisation
2.7.1. Cell monolayers. Cells were ¢xed, permeabilised and stained
as previously described [18]. They were viewed on a Zeiss photomicro-
scope III with epi£uorescence and standard wide band FITC ¢lters.
Photographs were taken on Kodak EPH P1600 ¢lm and processed at
1600 ASA.
2.7.2. Gelatin-TR. CHO cells cultured on gelatin-TR ¢lms were
¢xed with 4% formaldehyde in PBS freshly prepared from parafor-
maldehyde (5 min; rt), and wells washed with PBS. They were then
incubated (1 h; rt) with either normal sheep serum IgG (NSS), sheep
anti-MT1-MMP IgG (50 Wg/ml in PBS) or a⁄nity puri¢ed sheep anti-
MT1-MMP IgG (38 Wg/ml) together with 5% normal pig serum, fol-
lowed by a pig anti-sheep FabP-FITC [19] (1:400 in PBS with 5%
normal pig serum, 30 min, rt). Slides were mounted in Vectashield
(Vector Laboratories Inc, Burlingame, CA) and viewed on a MRC
600 confocal microscope with a krypton/argon laser. Data were col-
lected in two ways: (a) by simultaneously scanning both the 488 nm
(FITC, left) and 568 nm (Texas red, right) laser lines with a confocal
aperture of 0.5 and Kalman averaging over 10 scans, at slow scan
speed; (b) by collecting serial 1 Wm sections through cells and ¢lms (Z
series) and merging images with Bio-Rad Comos software using false
colour. Images were taken from the screen onto Agfapan 25 or Kodak
E100SW ¢lm. To assess the area of ¢lm degradation the Biorad Co-
mos software was used to outline on the screen the degradation below
at least 10 separate cells in duplicate wells (s 20 wells in all) and areas
averaged. Each experiment was repeated at least three times.
3. Results and discussion
3.1. Speci¢city of anti-human vMT1-MMP IgG
The speci¢city and sensitivity of sheep anti-human vMT1-
MMP IgGs were tested by Western blotting. The a⁄nity pu-
ri¢ed antibody recognised recombinant MT1-MMP (v502ÿ559)
[7] detecting pro-enzyme at 60 kDa and processed forms at 55
and 34 kDa (Fig. 1, lane 1) but did not recognise MT2-MMP
[20] (data not shown). The antibody recognised wild-type
MT1-MMP present in cell lysates from human infant foreskin
¢broblasts, detecting a major band at 60 kDa that was up-
regulated following treatment of the cells with PMA (Fig. 1,
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Fig. 2. MT1-MMP synthesis by human ¢broblasts is constitutive and upregulated by PMA. Human infant foreskin ¢broblasts were grown on
glass coverslips, then cultured for 24 h in either (a) DMEM or (b) DMEM with PMA 10 ng/ml. Monensin was added to the culture medium
for the last 19 h. The cells were then ¢xed and stained by indirect immuno£uorescence with the a⁄nity puri¢ed sheep IgG to MT1-MMP fol-
lowed by pig anti-sheep Fab-FITC. Bars = 20 Wm. a: Cells cultured in DMEM alone have weak perinuclear immuno£uorescence indicating con-
stitutive synthesis. b: Cells cultured with DMEM and PMA have enhanced perinuclear staining with many large secretory vesicles demonstrat-
ing increased MT1-MMP synthesis.
Fig. 1. Western blot of recombinant MMPs and cell lysates using
a⁄nity puri¢ed antibody to recombinant MT1-MMP. Recombinant
MMPs and cell lysates were electrophoresed on an SDS-10% poly-
acrylamide gel, blotted onto nitrocellulose membrane and probed
with a⁄nity puri¢ed antibody. Bound antibody was visualised with
a peroxidase conjugated second antibody followed by chemilumines-
cent detection. Lane 1, recombinant MT1-MMP; lane 2, recombi-
nant progelatinase A; lane 3, lysates prepared from untreated
HIFFs; lane 4, lysates prepared from HIFFs stimulated with PMA;
lane 5, lysate from control vector CHO cells; lane 6, lysate from
CHO cells transfected with MT1-MMP. Molecular mass markers
are indicated on the right.
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lanes 3, 4). A minor doublet at 63 kDa was detected in lysates
from stimulated cells (Fig. 1, lane 4), but was rarely present in
lysates from unstimulated cells. Bands of 60 and 63 kDa have
also been reported by Lohi et al. [21] in CCL-137 human
¢broblasts, using an antibody raised to the C-terminal intra-
cellular domain of MT1-MMP. Wild-type MT1-MMP was
not present in control vector transfected CHO cells (Fig. 1,
lane 5); when the pEE14 MT1-MMP construct was overex-
pressed in these cells, bands of 66, 60 and 45 kDa were de-
tected (Fig. 1, lane 6). We speculate that the 66 kDa form
corresponds to the pro-enzyme and that the 45 kDa band is a
truncated form of MT1-MMP, resulting from metalloprotei-
nase mediated processing (Stanton and Murphy, unpublished
results). This band is of a similar size to that detailed by Lohi
et al. [21], who also reported a band of 43 kDa in HT1080
human ¢brosarcoma cells stably transfected with MT1-MMP.
When blotted against other MMPs and TIMPs prepared
using a mammalian expression system as previously described
[22,23], the sheep anti-human vMT1-MMP IgGs did not rec-
ognise gelatinase A (Fig. 1, lane 2), collagenases 1, 2 and 3,
stromelysins 1 and 2, gelatinase B and TIMPs 1, 2 and 3 (data
not shown). NSO mouse myeloma cells stably transfected with
MT1-MMP cDNA stained brightly with the antibody using
immunolocalisation techniques, but NSO cells transfected
with TIMP-2 cDNA were negative (data not shown).
3.2. Fibroblast synthesis of MT1-MMP
Atkinson et al. [3] reported that low levels of MT1-MMP
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Fig. 3. CHO cells transfected with MT1-MMP express MT1-MMP on the cell surface and degrade gelatin ¢lms but cells transfected with
E217A MT1-MMP do not degrade the ¢lms: ¢lm degradation is inhibited by rTIMP-2 but not by rTIMP-1. CHO cells were grown on gelatin-
TR ¢lms and transiently transfected with equal amounts of either MT1-MMP cDNA (a, b, e, f), control vector cDNA (b) or E217A MT1-
MMP cDNA (d) and cultured for 19 h following glycerol shock. Either rTIMP-1 (e) or rTIMP-2 (f) were added to the culture media for 19 h.
Films were then ¢xed and stained by indirect immuno£uorescence with sheep anti-MT1-MMP IgG (a, c^f) or normal sheep IgG (b). Simultane-
ous scans were collected at 488 nm (FITC, left) and 568 nm (Texas red, right). Bar = 25 Wm. a: MT1-MMP-transfected cell has MT1-MMP im-
muno£uorescence on cell body and on membrane remaining on coverslip (arrow), and has degraded a pathway across the gelatin ¢lm during
the culture period. b: MT1-MMP transfected cells stained with NSS show ¢lm degradation but no cell immuno£uorescence. c: pEE12 vector
transfected cells have neither cell immuno£uorescence nor ¢lm degradation. d: E217A MT1-MMP transfected cells have cell surface immuno-
£uorescence but there is no ¢lm degradation. e: MT1 transfected cells cultured with TIMP-1: both cell staining of MT1-MMP and ¢lm degra-
dation are evident. f : MT1 transfected cells cultured with TIMP-2: cells have surface staining of MT1-MMP but there is no ¢lm degradation.
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mRNA and protein could be identi¢ed in unstimulated HIFFs
by Northern and Western blotting respectively. In order to
detect MT1-MMP protein by immuno£uorescence micros-
copy in normal (i.e. not transfected) cells, HIFFS were cul-
tured on coverslips and stained with sheep anti-MT1-MMP
antibody. Cells showed weak perinuclear immuno£uorescence
when the secretion inhibiting ionophore monensin was in-
cluded in the culture medium for 19 h prior to ¢xation (Fig.
2a) but cells cultured without monensin were negative (data
not shown), indicating that MT1-MMP protein synthesis is
slow but constitutive in these cells and follows the normal
secretory pathway. Cells cultured with monensin but incu-
bated with normal sheep serum (NSS) IgG did not stain
(data not shown). However, cells cultured with PMA for
24 h and monensin for the last 19 h showed much increased
perinuclear immuno£uorescence (Fig. 2b), in agreement with
Lohi et al. [21] who demonstrated that human ¢broblast ex-
pression of MT1-MMP mRNA was constitutive and en-
hanced 2^3-fold by treatment with PMA. Neither basal nor
stimulated cells showed any immuno£uorescence of external
cell membranes or cell surface associated staining.
3.3. Degradation of gelatin ¢lms
Sato et al. [1] showed that cells transfected with MT1-MMP
cDNA overexpressed MT1-MMP on the cell surface. MT1-
MMP has also been shown to have gelatinolytic activity in
vitro [5,7]. The question thus arose whether MT1-MMP could
be functionally gelatinolytic when expressed on the cell sur-
face. To address this question, we used a transient transfection
model system to overexpress MT1-MMP on the cell surface
and cultured these cells on a gelatin substrate. CHO L761H
cells were cultured on thin (V2 Wm measured by confocal
microscopy) ¢lms of gelatin labelled with Texas red, transi-
ently transfected with MT1-MMP cDNA, then stained by
indirect immuno£uorescence with anti-MT1-MMP antibody
to detect cells expressing MT1-MMP on their cell membranes.
The results are shown in Fig. 3 and summarised in Table 1.
On simultaneously scanning both channels (Fig. 3a) rings of
FITC immuno£uorescence at the level of the ¢lm were seen
on 20^30% of cells (Fig. 3a, left) indicating cell surface stain-
ing of MT1-MMP on transfected cells and, by collection of
1 Wm sections through the cells, staining was seen to cover the
entire cell surface (data not shown). In addition, at ¢lm level,
traces of MT1-MMP immuno£uorescence were seen separate
from the cells (Fig. 3a, arrow), presumably membrane depos-
its on the coverslip, detached as a result of cell movement
during the culture period. A substantial fraction of the cellular
integrins is known to be left behind on the substratum as the
cell detaches and locomotes [24], and these data suggest that
cell surface bound MT1-MMP may also remain attached to
the substratum. The gelatin-TR ¢lm had been degraded by
these cells, seen as dark feathery patches on an otherwise
homogeneous ¢lm (Fig. 3a, right). The ¢lm degradation
caused by MT1-MMP expressing cells was subjacent to the
cell and sharply demarcated, similar to the localised proteol-
ysis of opsonised ¢bronectin ¢lms by polymorphonuclear leu-
kocytes in the presence of proteinase inhibitors [25]. Tracks of
¢lm clearance were frequently observed, similar to phagoki-
netic tracks [26], illustrating proteolysis during cell migration.
Areas of ¢lm degradation were always associated with FITC
immuno£uorescence of cells and/or membrane deposits. Some
cells had no cell surface staining for MT1-MMP and no ad-
jacent ¢lm clearance; since degradation of the ¢lm was only
seen beneath cells with cell membrane staining we concluded
that these cells were not transfected and not actively produc-
ing cell membrane bound MT1-MMP. MT1-MMP trans-
fected cells stained with NSS showed tracts of ¢lm clearance
but no staining on the FITC channel (Fig. 3b) while cells
transfected with control vector only and stained with anti-
MT1-MMP antibody showed neither FITC immuno£uores-
cence nor ¢lm degradation (Fig. 3c). These data show that
¢lm removal is not due to either cell traction or the trans-
fection process, and the FITC £uorescence is not due to non-
speci¢c uptake of sheep IgG by CHO cells. The gelatin ¢lm
method we developed is similar to those used in other studies
[27,28] but, by mild ¢xation of the gelatin to the glass slide,
removal of the ¢lm by cell traction is prevented. Scanning on
both channels with confocal laser light allows visualisation of
small areas of ¢lm clearance without interference from £are
from surrounding intact ¢lm, together with identi¢cation of
cells expressing enzyme on the cell membrane.
We then transfected CHO cells with an E217A mutant
MT1-MMP cDNA that yields inactive MT1-MMP. Fig. 3d
shows that cell surface MT1-MMP immuno£uorescence was
present on these cells but no subjacent ¢lm degradation was
seen, demonstrating that the ¢lm degradation previously ob-
served was due to the catalytic activity of MT1-MMP.
MT1-MMP transfected cells were incubated with recombi-
nant human TIMP-1 (10 Wg/well) : Fig. 3e shows that cell
surface immuno£uorescence was present and degradation of
the ¢lm was observed. However, no ¢lm degradation took
place when transfected cells were incubated with either re-
combinant TIMP-2 (10 Wg/well ; Fig. 3f) or CT1399 (10 WM;
data not shown), although FITC immuno£uorescence was
observed on cell surfaces, con¢rming the presence of MT1-
MMP. CHO cells are known to synthesise very low levels of
gelatinases A and B which could have contributed to the ¢lm
degradation, but TIMP-1 is known to be a good inhibitor of
gelatinase A and an extremely poor inhibitor of MT1-MMP
[16]. Inclusion of aprotinin in wells containing MT1-MMP
transfected cells had no e¡ect on either cell surface staining
or ¢lm degradation, indicating that plasminogen activators do
not play a role in this system. We therefore concluded that
degradation of the gelatin-TR ¢lm was due to proteolysis by
MT1-MMP. Furthermore, for proteolysis to occur, a require-
ment for MT1-MMP at the cell surface was noted. HIFFs
stimulated with PMA and grown on gelatin ¢lms expressed
MT1-MMP intracellularly, but not at the surface (Fig. 2b)
and no ¢lm degradation was observed (data not shown). In-
terestingly, proteolysis of the gelatin ¢lm by transfected CHO
cells was associated with processing of MT1-MMP to a
45 kDa form as detected by Western blot analysis. In con-
trast, PMA stimulated HIFFs which did not degrade the ¢lms
had MT1-MMP bands at 63 and 60 kDa but none of the
45 kDa form was detected in the lysate.
Puri¢ed recombinant progelatinase A (0.001^1.0 Wg/well)
was then added to MT1-MMP transfected cells. MT1-MMP
cell surface immuno£uorescence was observed in all wells as
before, indicating that even at the highest concentration pro-
gelatinase did not interfere with antibody-MT1-MMP bind-
ing. However, ¢lm degradation, again seen as tracts only be-
low cells with FITC staining, increased in area with increasing
amounts of progelatinase. At 0.1 Wg the margins of the area
degraded by a single cell greatly exceeded the cell diameter,
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whereas without progelatinase the cell tract or hole approxi-
mated the cell diameter (see Fig. 3a,e). This is demonstrated
by the area measurements (Table 1): variations in individual
cell locomotion and local cell densities contribute to large
standard errors. These results suggest that, whereas ¢lm deg-
radation by MT1-MMP is immediately subjacent to the cell
membrane, degradation by gelatinase may not be. Whether
enzyme/cell membrane detached from the cell body during
cell locomotion is also able to continue ECM proteolysis
has yet to be determined.
These data demonstrate that cells expressing MT1-MMP on
their cell membranes exhibit subjacent proteolysis of a gelatin
¢lm and that this proteolysis is inhibited by addition of
TIMP-2 or a hydroxamate inhibitor, but not by TIMP-1.
Thus, expression of MT1-MMP on the cell surface may lead
to both progelatinase A activation and extracellular matrix
degradation. We are currently investigating the use of other
substrates and the gelatin ¢lm method developed for this work
should be useful for studying the properties of the other MT-
MMPs.
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